Compounding and the Courts

Sign On

Author(s): Gibbs Jeffrey N, Wasserstein Jeffrey N

Issue: Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues
View All Articles in Issue

Abstract:

Related Keywords: FDAMA Section 503A, effect of

Related Categories: BUSINESS, LEGAL

Printer-Friendly Version

Download in electronic PDF format for $35

Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy

Related Articles from IJPC
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A	Blankenship Cynthia E	Sep/Oct 2014	379-380	Buy
Compounding and the Courts	Gibbs Jeffrey N, Wasserstein Jeffrey N	Jul/Aug 2002	263-266	Buy
Basics of Compounding for Terrorist Attacks, Part 2	Allen Loyd V Jr	Mar/Apr 2003	129-134	View Sample
Pharmacogenomics: Precision Pharmacy in 503A Compounding	Drummond Joseph, Bennet Daron, Allen Loyd V Jr	Mar/Apr 2018	95-107	Buy
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies	Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018	7-16	Buy
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success	Pritchett Jon, Mixon William, O'Connell Kevin	Jan/Feb 2016	29-36	Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies	Yoch Doug	Mar/Apr 2017	95-102	Buy
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum	Zur Eyal	Mar/Apr 2012	117-124	Buy
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags	Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M	Mar/Apr 2004	156-159	Buy
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns	Allen Loyd V Jr	Jan/Feb 1999	25-29	Buy